Cerity Partners
TMCI icon

Cerity Partners’s Treace Medical Concepts TMCI Stock Holding History

Cerity Partners’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Buy
29,997
+15,672
+109% +$43.1K ﹤0.01% 3184
2026
Q1 		$19.2K Sell
14,325
-2,271
-14% -$4.53K ﹤0.01% 3184
2025
Q4 		$40.7K Buy
16,596
+2,423
+17% +$10.5K ﹤0.01% 2818
2025
Q3 		$95.1K Buy
14,173
+3,060
+28% +$20K ﹤0.01% 2633
2025
Q2 		$65.3K Buy
11,113
+376
+4% +$2.45K ﹤0.01% 2533
2025
Q1 		$90.1K Sell
10,737
-1,107
-9% -$9.95K ﹤0.01% 2334
2024
Q4 		$83K Hold
11,844
– – ﹤0.01% 2352
2024
Q3 		$68.7K Sell
11,844
-1,581
-12% -$10.2K ﹤0.01% 2460
2024
Q2 		$89.3K Buy
+13,425
New +$108K ﹤0.01% 2121

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $118M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerity Partners's TMCI Position: Q2 2026 in Review

Cerity Partners increased its Treace Medical Concepts (TMCI) stake by 109% in Q2 2026, buying an estimated $43.1K and bringing the position to 29,997 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3184.

Cerity Partners first reported a position in TMCI in Q2 2024 and has held it in 9 quarters since. 101 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Cerity Partners held 29,997 shares of Treace Medical Concepts worth $119K as of Q2 2026.
  • Cerity Partners bought 15,672 Treace Medical Concepts shares in Q2 2026, an estimated $43.1K.
  • Treace Medical Concepts made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3184 holding.
  • Cerity Partners first reported a position in Treace Medical Concepts in Q2 2024 and has held it in 9 quarters since.
  • 101 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.